4.5 Article

DNA methylation in schizophrenia subjects: gender and MTHFR 677C/T genotype differences

期刊

EPIGENOMICS
卷 4, 期 3, 页码 261-268

出版社

FUTURE MEDICINE LTD
DOI: 10.2217/EPI.12.25

关键词

females; folate; metabolic syndrome; methylation; MTHFR; schizophrenia

资金

  1. NIMH [R01 MH082784-01]
  2. NIH-NCCR, GCRC Program [UL1RR024986]
  3. Chemistry Core of the Michigan Diabetes Research and Training Center [NIH5P60 DK 20572]
  4. Washtenaw Community Health Organization

向作者/读者索取更多资源

Aim: In schizophrenia, metabolic syndrome incidence is double that of the general population, with women having a higher incidence. Pharmacogenetically regulated folic acid may be related to this risk. DNA methylation and metabolic syndrome within this group has not been previously studied. Methods: Metabolic syndrome was evaluated with fasting laboratory measurements, and dietary and lifestyle assessments. Methylation analysis used a peripheral sample for the LINE-1 assay. DNA was also genotyped for MTHFR 677C/T. Results: This analysis included 133 subjects. We found a significant relationship between LINE-1 methylation, and an interaction between MTHFR and gender, controlling for serum folate (p = 0.008). Females with the 677TT genotype had the lowest methylation (56%) compared with the other groups (75%). Conclusion: TT genotype females had the lowest methylation, which may explain metabolic syndrome gender differences in schizophrenia. Folate supplementation may be a suggested intervention within schizophrenia; however, additional work is required.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Sport Sciences

Epigenetic Responses to Acute Resistance Exercise in Trained vs. Sedentary Men

James R. Bagley, Kyle J. Burghardt, Ryan McManus, Bradley Howlett, Pablo B. Costa, Jared W. Coburn, Jose A. Arevalo, Moh H. Malek, Andrew J. Galpin

JOURNAL OF STRENGTH AND CONDITIONING RESEARCH (2020)

Article Psychiatry

Metabolic syndrome is negatively associated with cognition among endothelial nitric oxide synthase (eNOS)-786C carriers in schizophrenia-spectrum disorders

A. Zarina Kraal, Allison C. Moll, Nicole R. Arvanitis, Kristen M. Ward, Ryan J. Doughert, Tyler B. Grove, Kyle J. Burghardt, Vicki L. Ellingrod

JOURNAL OF PSYCHIATRIC RESEARCH (2019)

Article Clinical Neurology

Skeletal muscle DNA methylation modifications and psychopharmacologic treatment in bipolar disorder

Kyle J. Burghardt, Bradley H. Howlett, Elani Sanders, Sabrina E. Dass, Zaher Msallaty, Abduallah Mallisho, Berhane Seyoum, Zhengping Yi

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2019)

Review Pharmacology & Pharmacy

Antipsychotic Medications and DNA Methylation in Schizophrenia and Bipolar Disorder: A Systematic Review

Kyle J. Burghardt, Audrey S. Khoury, Zaher Msallaty, Zhengping Yi, Berhane Seyoum

PHARMACOTHERAPY (2020)

Review Pharmacology & Pharmacy

Personal genotyping and student outcomes in genetic and pharmacogenetic teaching: a systematic review and meta-analysis

Kyle J. Burghardt, Kristen M. Ward, Bradley H. Howlett, Paul R. Burghardt

Summary: Teaching genetics and pharmacogenetics with personal genotyping (PGT) can improve student attitudes, perceptions, and knowledge.

PHARMACOGENOMICS (2021)

Article Endocrinology & Metabolism

Metformin Increases Protein Phosphatase 2A Activity in Primary Human Skeletal Muscle Cells Derived from Lean Healthy Participants

Aktham Mestareehi, Xiangmin Zhang, Berhane Seyoum, Zaher Msallaty, Abdullah Mallisho, Kyle Jon Burghardt, Anjaneyulu Kowluru, Zhengping Yi

Summary: The study found that metformin significantly increased PP2A activity in the skeletal muscle of 8 lean healthy insulin-sensitive participants, providing insight into metformin's mechanism of action in human skeletal muscle.

JOURNAL OF DIABETES RESEARCH (2021)

Article Neurosciences

Profiling the Skeletal Muscle Proteome in Patients on Atypical Antipsychotics and Mood Stabilizers

Kyle J. Burghardt, Griffin Calme, Michael Caruso, Bradley H. Howlett, Elani Sanders, Zaher Msallaty, Abdullah Mallisho, Berhane Seyoum, Yue A. Qi, Xiangmin Zhang, Zhengping Yi

Summary: This study aimed to measure protein abundance in the skeletal muscle of patients on long-term treatment with atypical antipsychotics (AAP) or mood stabilizers. Significant differences in proteomic profiles were identified between the AAP group and the mood stabilizer group, suggesting that proteinomic characteristics may be associated with the metabolic side effects caused by these medications.

BRAIN SCIENCES (2022)

Review Pharmacology & Pharmacy

The effect of antipsychotic treatment on hormonal, inflammatory, and metabolic biomarkers in healthy volunteers: A systematic review and meta-analysis

Kyle Jon Burghardt, Wasym Mando, Berhane Seyoum, Zhengping Yi, Paul Ryen Burghardt

Summary: This systematic review and meta-analysis examined the evidence of hormonal, inflammatory, and metabolic biomarker studies of antipsychotic treatment in study designs using healthy volunteers. The findings suggest that antipsychotics may have strong effects on several biomarkers independent of psychiatric disease, but further replication work is needed for many biomarkers.

PHARMACOTHERAPY (2022)

Review Genetics & Heredity

Epigenome-wide studies of antipsychotics: a systematic review and pathway meta-analysis

Thomas Rowbal, Megan Kajy, Kyle J. Burghardt

Summary: This study aims to understand the mechanisms of antipsychotics through epigenetics. The findings demonstrate that the studies of the epigenome and antipsychotic treatment are highly heterogeneous in nature. This can inform future studies to target cross-cutting gene sets and pathways.

EPIGENOMICS (2023)

Article Pharmacology & Pharmacy

Bibliometric data based on the Pharm.D. and Ph.D. degree in United States research-intensive colleges of pharmacy

Kyle J. Burghardt, Bradley H. Howlett, Audrey S. Khoury, Stephanie M. Fern, Paul R. Burghardt

Summary: This study compared the bibliometrics based on doctoral degrees within United States colleges of pharmacy and found significant differences in scholarly metrics between different degrees. Future research should focus on exploring potential variables that explain these differences.

INTERNATIONAL JOURNAL OF PHARMACY PRACTICE (2021)

Meeting Abstract Neurosciences

Genetic Endocannabinoid Variation Does Not Predict Differential Neural Fear Activation During Fear Extinction in Healthy Humans: A Preliminary Study

Nicole Zabik, Allesandra Iadipaolo, Craig Peters, Kyle Burghardt, Christine Rabinak

NEUROPSYCHOPHARMACOLOGY (2020)

Article Information Science & Library Science

Three Commonly Utilized Scholarly Databases and a Social Network Site Provide Different, But Related, Metrics of Pharmacy Faculty Publication

Kyle J. Burghardt, Bradley H. Howlett, Audrey S. Khoury, Stephanie M. Fern, Paul R. Burghardt

PUBLICATIONS (2020)

Article Public, Environmental & Occupational Health

A bibliometric analysis of the top 50 NIH-Funded colleges of pharmacy using two databases

Kyle J. Burghardt, Bradley H. Howlett, Stephanie M. Fern, Paul R. Burghardt

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY (2020)

Meeting Abstract Neurosciences

Endocannabinoid Regulation of Fear-Extinction Neural Circuitry in Youth: Effects of FAAH Genotype

Hilary Marusak, Craig Peters, Allesandra Iadipaolo, Farrah Elrahal, Kyle Burghardt, Christine Rabinak

NEUROPSYCHOPHARMACOLOGY (2019)

Article Biochemistry & Molecular Biology

Atypical Antipsychotics and the Human Skeletal Muscle Lipidome

Kyle J. Burghardt, Kristen M. Ward, Elani J. Sanders, Bradley H. Howlett, Berhane Seyoum, Zhengping Yi

METABOLITES (2018)

暂无数据